Cargando…
How do patients and other members of the public engage with the orphan drug development? A narrative qualitative synthesis
BACKGROUND: The diversity of patient experiences of orphan drug development has until recently been overlooked, with the existing literature reporting the experience of some patients and not others. The current evidence base (the best available current research) is dominated by quantitative surveys...
Autores principales: | Frost, Julia, Hall, Abi, Taylor, Emily, Lines, Sarah, Mandizha, Jessica, Pope, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108537/ https://www.ncbi.nlm.nih.gov/pubmed/37069597 http://dx.doi.org/10.1186/s13023-023-02682-w |
Ejemplares similares
-
Civic engagement among orphans and non-orphans in five low- and middle-income countries
por: Gray, Christine L., et al.
Publicado: (2016) -
How do public health professionals view and engage with research? A qualitative interview study and stakeholder workshop engaging public health professionals and researchers
por: van der Graaf, Peter, et al.
Publicado: (2017) -
Orphan Drugs in Neurology—A Narrative Review
por: Sirbu, Carmen Adella, et al.
Publicado: (2023) -
Proteomics, Holm Oak (Quercus ilex L.) and Other Recalcitrant and Orphan Forest Tree Species: How do They See Each Other?
por: Rey, María-Dolores, et al.
Publicado: (2019) -
Stimulating the development of orphan (and other) vaccines.
por: Schwartz, B, et al.
Publicado: (1999)